Has Joseph Shams, MD received payments from drug or device companies?

Yes. Drug and device makers reported $136,025 in general payments to Joseph Shams, MD across 239 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joseph Shams, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joseph Shams, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joseph Shams, MD

Vascular & Interventional Radiology · New York, NYNPI 1659301125

Payments from drug & device makers

What this record shows

This record is dominated by other: $104,333 of the $136,025 with a category attached, or 76.7%. Angiodynamics, Inc. accounts for 96.0% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $48,881 and has fallen 66.7% since, to $16,260 in 2025. Among vascular & interventional radiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$136,025in general payments, 2019–2025

Across 239 payments — averaging $569.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Angiodynamics, Inc.$131K
Cardiovascular Systems Inc.$2K
Philips North America LLC$1K
Medtronic$444
Cook Incorporated$422
Vasorum USA Inc.$419
plus $1K from 12 others

$100,000in ownership & investment interests, 2019–2025

Across 3 payments — averaging $33,333 each. An ownership or investment interest held by the physician or an immediate family member.

Vasorum USA Inc.$100K

What the payments were for

Consulting fees$7501%
Travel & lodging$1,2121%
Food & beverage$5,9384%
Education$23,79217%
Other$104,33377%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Angiodynamics, Inc.	110	$130,630
Cardiovascular Systems Inc.	81	$1,542
Philips North America LLC	5	$1,339
Medtronic	8	$444
Cook Incorporated	2	$422
Vasorum USA Inc.	1	$419
Globus Medical	2	$238
Johnson & Johnson	6	$220
Abbott	9	$206
Shockwave Medical, Inc	1	$148
Veryan Medical Incorporated	2	$117
Terumo Medical Corporation	3	$70
Tactile Systems Technology Inc	2	$62
Bard Peripheral Vascular, Inc.	1	$46
Biotronik Inc.	2	$37
Intact Vascular, Inc.	2	$36
Nevro Corp.	1	$31
Capsovision, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Auryon Laser System 100-120 Vac$125,741
Auryon$2,875
CVX-300$750
Lasers$578
CELT ACD$419
Cook Medical Zilver PTX$327
Diamondback Peripheral$313
Senza$182
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$148
Abre$126
HawkOne$112
ClosureFast$107

How this compares

$136,025 in reported general payments places this provider in the 95th percentile of 306 vascular & interventional radiology providers in New York.

See all vascular & interventional radiology providers in New York →

Medicare billing

Part B allowed, 2024

$596,678

Medicare patients

281

Services billed

3,869

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	14	$61

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in New York

Edward KimNew York$831K
Robert LooksteinNew York$515K
Rahul PatelNew York$275K
Aaron FischmanNew York$240K
Philip MeyersNew York$238K
Abigail FalkNew York$214K
Robert RosenNew York$199K
Asad BaigNew York$137K
Joshua WeintraubNew York$137K
Ryan HickeyNew York$122K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →